DEREK AUBE-MARCHANT: Open Payments
NPI 1972736825 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,312 in 131 payments from 24 companies in 2025. Trend: 2023 $2,226 · 2024 $2,425 · 2025 $2,312
Food & beverage: $2,270Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $385 |
| Lilly USA, LLC | 20 | $359 |
| ABBVIE INC. | 13 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $184 |
| GlaxoSmithKline, LLC. | 14 | $180 |
| PFIZER INC. | 11 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Edwards Lifesciences Corporation | 3 | $80 |
| Exact Sciences Corporation | 3 | $74 |
Products named: JARDIANCE, MOUNJARO, Wegovy, ZEPBOUND, UBRELVY, TRELEGY ELLIPTA, CAPLYTA, REXULTI.
Industry payments across NY — which companies pay providers there.
